Literature DB >> 15148219

Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.

J A P Gomes1, R Amankwah, A Powell-Richards, H S Dua.   

Abstract

PURPOSE: Sodium hyaluronate (hyaluronic acid) is known to promote corneal epithelial wound healing in vivo and in vitro, in animal experiments. Sodium hyaluronate is the ligand for CD44, a cell surface adhesion molecule which has been found on normal human corneal epithelial cells. The purpose of this study was to investigate the effect of sodium hyaluronate on human corneal epithelial cell migration, proliferation, and CD44 receptor expression.
METHODS: Human corneal epithelial cell cultures were established from 32 donor corneoscleral rims and maintained separately in three different culture conditions: (1) culture medium only, (2) sodium hyaluronate enriched (0.6 mg/ml) medium, and (3) hydroxypropylmethylcellulose enriched (2.5 mg/ml) medium. The total area of migrating epithelial cell sheets in each case was measured by planimetry on days 4, 8, 12, and 16. Cytospin preparations of cells cultured in the different culture conditions were examined immunohistochemically for proliferation and CD44 receptor expression using antibodies directed against Ki67 and CD44 respectively.
RESULTS: Cells cultured in the presence of sodium hyaluronate showed significantly increased migration at days 12 and 16 (Friedmen test: p = 0.0012, day 16; p = <0.001, day 12) compared with cells cultured in the other media. There was no difference in cell proliferation (Ki67) or CD44 expression on cells cultured in the different culture conditions.
CONCLUSIONS: Sodium hyaluronate promotes migration but not proliferation or CD44 expression on human corneal epithelial cells in vitro. The beneficial effect of sodium hyaluronate in corneal wound healing is likely to be related to rapid migration of cells leading to rapid wound closure. This may be facilitated by the adhesion between CD44 on the cells and hyaluronic acid, which coats the surface of the denuded cornea.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148219      PMCID: PMC1772195          DOI: 10.1136/bjo.2003.027573

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  51 in total

1.  Synergistic effects of hyaluronan and fibronectin on epithelial migration in rabbit cornea in vitro.

Authors:  M Nakamura; T Nishida
Journal:  Cornea       Date:  1999-11       Impact factor: 2.651

2.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  Fibronectin eyedrops for traumatic recurrent corneal lesion.

Authors:  T Nishida; S Nakagawa; T Awata; Y Tani; R Manabe
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Proteoglycan changes during restoration of transparency in corneal scars.

Authors:  J R Hassell; C Cintron; C Kublin; D A Newsome
Journal:  Arch Biochem Biophys       Date:  1983-04-15       Impact factor: 4.013

6.  The protective effect of Na-hyaluronate to corneal endothelium.

Authors:  E L Graue; F M Polack; E A Balazs
Journal:  Exp Eye Res       Date:  1980-07       Impact factor: 3.467

7.  Cytologic and histochemical changes in corneal wound repair.

Authors:  S Kitano; J N Goldman
Journal:  Arch Ophthalmol       Date:  1966-09

8.  Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo.

Authors:  T Nishida; S Nakagawa; C Nishibayashi; H Tanaka; R Manabe
Journal:  Arch Ophthalmol       Date:  1984-03

9.  Peroperative protection of cornea and conjunctiva.

Authors:  M S Norn
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-08

10.  Cytotoxicity of viscoelastics on cultured corneal epithelial cells measured by plasminogen activator release.

Authors:  T D Lindquist; M Edenfield
Journal:  J Refract Corneal Surg       Date:  1994 Mar-Apr
View more
  57 in total

1.  Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.

Authors:  Françoise Brignole; Pierre-Jean Pisella; Bénédicte Dupas; Vincent Baeyens; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

2.  Comparison of cytotoxicity and wound healing effect of carboxymethylcellulose and hyaluronic acid on human corneal epithelial cells.

Authors:  Jong Soo Lee; Seung Uk Lee; Cheng-Ye Che; Ji-Eun Lee
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  A hyaluronan hydrogel scaffold-based xeno-free culture system for ex vivo expansion of human corneal epithelial stem cells.

Authors:  D Chen; Y Qu; X Hua; L Zhang; Z Liu; S C Pflugfelder; D-Q Li
Journal:  Eye (Lond)       Date:  2017-02-17       Impact factor: 3.775

4.  Use of commercially available sodium hyaluronate 0.18% eye drops for corneal epithelial healing in diabetic patients.

Authors:  KietPhang Ling; Mae-Lynn Catherine Bastion
Journal:  Int Ophthalmol       Date:  2018-12-07       Impact factor: 2.031

5.  Involvement of the MEKK1 signaling pathway in the regulation of epicardial cell behavior by hyaluronan.

Authors:  Evisabel A Craig; Patti Parker; Anita F Austin; Joey V Barnett; Todd D Camenisch
Journal:  Cell Signal       Date:  2010-02-14       Impact factor: 4.315

Review 6.  The role and treatment of inflammation in dry eye disease.

Authors:  Ayse Yagci; Canan Gurdal
Journal:  Int Ophthalmol       Date:  2014-07-26       Impact factor: 2.031

7.  Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye.

Authors:  Michael E Johnson; Paul J Murphy; Mike Boulton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

Review 8.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

9.  Controlled release of high molecular weight hyaluronic Acid from molecularly imprinted hydrogel contact lenses.

Authors:  Maryam Ali; Mark E Byrne
Journal:  Pharm Res       Date:  2009-01-21       Impact factor: 4.200

10.  Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels.

Authors:  Bin Duan; Laura A Hockaday; Edi Kapetanovic; Kevin H Kang; Jonathan T Butcher
Journal:  Acta Biomater       Date:  2013-05-03       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.